
Is this how healthcare will be optimized in the future?
Healthcare leaders in government, policy and industry worldwide must work to create an environment where innovation thrives and its adoption is seamless.
Fresenius SE (Frankfurt/Xetra: FRE) is a global healthcare company headquartered in Bad Homburg v. d. Höhe, Germany. In fiscal year 2025, the healthcare group, with more than 178,000 employees, generated €22.6 billion in annual revenue. With its focus on therapy, Fresenius offers products and services for the care of critically and chronically ill patients.
Fresenius comprises Fresenius Kabi and Fresenius Helios as well as the investment company Fresenius Medical Care. With around 140 hospitals and 340 outpatient facilities, Fresenius Helios is the largest private hospital operator in Europe, treating around 27 million patients every year. Fresenius Kabi’s product portfolio includes biopharmaceuticals, clinical nutrition, medical technology, and intravenous generic drugs and fluids, reaching approximately 450 million patients annually.
Healthcare leaders in government, policy and industry worldwide must work to create an environment where innovation thrives and its adoption is seamless.
AI can dramatically improve outcomes and introduce cost-saving efficiencies in the medical sector – but healthcare professionals must decide how to deploy the technology


